Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Recruiting 5Completed 4Withdrawn 2Unknown 1

Sponsor Class

OTHER 2UNKNOWN 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Pancreatic Neoplasms 2Head and Neck Neoplasms 2Stomach Neoplasms 1Resectable Pancreatic Cancer 1Penile Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Glioma 1Glioblastoma 1Esophageal 1Diffuse Intrinsic Pontine Glioma 1Colorectal Neoplasms 1Advanced and/or Metastatic Solid Tumours 1Advanced Esophageal 1Adenocarcinoma 1

Interventions

Cisplatin 90Fluorouracil 76Radiotherapy 63Paclitaxel 58Docetaxel 49Oxaliplatin 48Irinotecan 42Leucovorin 32Capecitabine 31Carboplatin 27Radiation 21Surgical Procedures, Operative 20Esophagectomy 20pembrolizumab 15Neoadjuvant Therapy 15Bevacizumab 15Cetuximab 13Drug Therapy 12Epirubicin 11Chemotherapy, Adjuvant 9S 1 (combination) 8Magnetic Resonance Spectroscopy 8Gemcitabine 8Trastuzumab 7Nivolumab 7Erlotinib Hydrochloride 7Surveys and Questionnaires 6Panitumumab 6Immunohistochemistry 6Chemoradiotherapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Esophageal Neoplasms × nimotuzumab × Clear all
NCT06048913 2025-07-04

Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Treatment Esophageal Cancer in Old Age

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Completed
56 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01249352 2025-03-31

NICE

Eurofarma Laboratorios S.A.

Phase 2/3 Completed
104 enrolled
Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT04207918 2024-05-16

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Completed
55 enrolled
Gastrointestinal

Esophageal Neoplasms

NCT01463605 2021-02-04

Nimotuzumab Combined With Radiotherapy for Older Patients With Esophageal Cancer: a Single, Non-control Clinical Trial

ChineseAMS

Phase 2 Completed
46 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡